Global LVAD Market Report: 2015 Edition
Left ventricular assist devices (LVADs) are mechanical heart pumps used to support a failing heart in patients with advanced heart failure. LVADs are lifesaving modules for patients who need temporary cardiac assistance and for those waiting for heart transplantation. They are used in the bridge-to-transplantation (BTT), destination therapy (DT) and bridge to recovery. LVAD is a key potential area of focus for researchers and various manufacturers at present. The cost-effectiveness and increased insurance reimbursement conditions are likely to increase the demand for LVADs in the future.
The report “Global LVAD Market” provides a comprehensive analysis of the global market for LVAD, global BTT and DT market along with in-depth study of the US market and focus on application area worldwide. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The three major players in the industry, Thoratec Corporation, Heartware International Inc. and Abiomed Inc. are being profiled.
The key factors driving the growth of the LVAD market are increasing diabetic population, rising healthcare expenditure, ageing population and technological developments. Some of the noteworthy trend and developments of this industry are new product development and expansion in number of LVAD centers. However, the expansion of global LVAD market is hindered by serious adverse events with implantable LVADs and barriers for DT adoption
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
The report “Global LVAD Market” provides a comprehensive analysis of the global market for LVAD, global BTT and DT market along with in-depth study of the US market and focus on application area worldwide. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The three major players in the industry, Thoratec Corporation, Heartware International Inc. and Abiomed Inc. are being profiled.
The key factors driving the growth of the LVAD market are increasing diabetic population, rising healthcare expenditure, ageing population and technological developments. Some of the noteworthy trend and developments of this industry are new product development and expansion in number of LVAD centers. However, the expansion of global LVAD market is hindered by serious adverse events with implantable LVADs and barriers for DT adoption
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. OVERVIEW
1.1 Heart Failure
1.1.1 Introduction
1.1.2 Various Stages of Heart Failure
1.1.3 Available Treatment Options for HF
1.2 Ventricular Assist Device
1.2.1 Type of VADS
1.2.2 Applications
1.3 LVAD: An Overview
2. LVAD MARKET ANALYSIS
2.1 Global Market
Market Value
Market Volume
Penetration Rate
2.2 The US LVAD Market
Market Value
Market Volume
Market Segments
Penetration Rate
Implant Volume Growth
3. MARKET DYNAMICS
3.1 Key Trends and Development
3.1.1 New Product Development
3.1.2 Expansion in the Number of LVAD Centers
3.2 Growth Drivers
3.2.1 Technological Advancements
3.2.2 Growing Ventricular Assist Devices (VADs) Therapy
3.2.3 Ageing Population Worldwide
3.2.4 Increasing Diabetic Population
3.2.5 Rising Healthcare Expenditure
3.2.6 Economic Growth
3.3 Challenges
3.3.1 Serious Adverse Events with Implantable LVADs
3.3.2 Barriers for DT Adoption
4. COMPETITIVE LANDSCAPE
5. COMPANY PROFILES
5.1 Thoratec Corporation
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Heartware International Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 Abiomed, Inc.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
1.1 Heart Failure
1.1.1 Introduction
1.1.2 Various Stages of Heart Failure
1.1.3 Available Treatment Options for HF
1.2 Ventricular Assist Device
1.2.1 Type of VADS
1.2.2 Applications
1.3 LVAD: An Overview
2. LVAD MARKET ANALYSIS
2.1 Global Market
Market Value
Market Volume
Penetration Rate
2.2 The US LVAD Market
Market Value
Market Volume
Market Segments
Penetration Rate
Implant Volume Growth
3. MARKET DYNAMICS
3.1 Key Trends and Development
3.1.1 New Product Development
3.1.2 Expansion in the Number of LVAD Centers
3.2 Growth Drivers
3.2.1 Technological Advancements
3.2.2 Growing Ventricular Assist Devices (VADs) Therapy
3.2.3 Ageing Population Worldwide
3.2.4 Increasing Diabetic Population
3.2.5 Rising Healthcare Expenditure
3.2.6 Economic Growth
3.3 Challenges
3.3.1 Serious Adverse Events with Implantable LVADs
3.3.2 Barriers for DT Adoption
4. COMPETITIVE LANDSCAPE
5. COMPANY PROFILES
5.1 Thoratec Corporation
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Heartware International Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 Abiomed, Inc.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
LIST OF CHARTS
Types of Heart Failure
Global LVAD Market – by Value (2011-2015E)
Global LVAD Market (2011-2016E)
Global LVAD Penetration Rate (2011-2016E)
The US LVAD Market – by Value (2011-2016E)
The US LVAD Market by Volume (2011-2016E)
The US BTT Penetration Rate (2011-2016E)
The US DT Penetration Rate (2011-2016E)
The US Annual BTT LVAD Implants (2011-2015E)
The US Annual DT LVAD Implants (2011-2015E)
CAGR by Center Volume (2014-2016E)
BTT Implant Volume Growth (2013-2016E)
DT Implant Volume Growth (2013-2016E)
Ageing Population Worldwide (2006-2014)
Global Diabetic Population (2006-2014)
Global Healthcare Expenditure (2007-2014)
Global GDP (2006-2013)
The US LVAD Market Share by Company (2014)
OUS LVAD Market Share by Company (2014)
The US BTT LVAD Volume Share by Company (2014)
The US DT Volume Share by Company (2014)
Thoratec’s Revenue Breakdown by Product Line (2014)
Thoratec’s Revenue Breakdown by Geographic Region (2014)
Thoratec’s Revenue Breakdown by Category (2014)
Thoratec’s Revenue and Net Income (2010-2014)
Heartware’s Revenue by Geographical Segment (2014)
Heartware’s Revenue and Net Income (2010-2014)
Abiomed’s Revenue Breakdown by Products (2014 15)
Abiomed’s Revenue and Net Income (2010 11 2014 15)
Global LVAD Market Forecast (2014-2018E)
Types of Heart Failure
Global LVAD Market – by Value (2011-2015E)
Global LVAD Market (2011-2016E)
Global LVAD Penetration Rate (2011-2016E)
The US LVAD Market – by Value (2011-2016E)
The US LVAD Market by Volume (2011-2016E)
The US BTT Penetration Rate (2011-2016E)
The US DT Penetration Rate (2011-2016E)
The US Annual BTT LVAD Implants (2011-2015E)
The US Annual DT LVAD Implants (2011-2015E)
CAGR by Center Volume (2014-2016E)
BTT Implant Volume Growth (2013-2016E)
DT Implant Volume Growth (2013-2016E)
Ageing Population Worldwide (2006-2014)
Global Diabetic Population (2006-2014)
Global Healthcare Expenditure (2007-2014)
Global GDP (2006-2013)
The US LVAD Market Share by Company (2014)
OUS LVAD Market Share by Company (2014)
The US BTT LVAD Volume Share by Company (2014)
The US DT Volume Share by Company (2014)
Thoratec’s Revenue Breakdown by Product Line (2014)
Thoratec’s Revenue Breakdown by Geographic Region (2014)
Thoratec’s Revenue Breakdown by Category (2014)
Thoratec’s Revenue and Net Income (2010-2014)
Heartware’s Revenue by Geographical Segment (2014)
Heartware’s Revenue and Net Income (2010-2014)
Abiomed’s Revenue Breakdown by Products (2014 15)
Abiomed’s Revenue and Net Income (2010 11 2014 15)
Global LVAD Market Forecast (2014-2018E)
LIST OF TABLES
Stages of Heart Failure by AHA and ACC
NYHA Classification of Heart Failure
Global LVAD Market by Application Area (2011-2015E)
The US LVAD Market by Application Area (2011-2015E)
Financial Comparison of Key Players (2014)
Dependent & Independent Variables (2008–2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Stages of Heart Failure by AHA and ACC
NYHA Classification of Heart Failure
Global LVAD Market by Application Area (2011-2015E)
The US LVAD Market by Application Area (2011-2015E)
Financial Comparison of Key Players (2014)
Dependent & Independent Variables (2008–2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
